Calypso; (Z)-thiacloprid; (3-((6-Chloro-3-pyridinyl)methyl)-2-thiazolidinylidene)cyanamide; (E)-thiacloprid; UNII-DSV3A944A4; [3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene]cyanamide; Cyanamide, [3-[(6-chloro-3-pyridinyl)methyl]-2-thiazolidinylidene]-; CHEMBL451432; DSV3A944A4; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide; {3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide; Calypso 70WG; [3-(6-Chloro-3-pyridinylmethyl)-2-thiazolidinylidene]cyanamide; [3-[(6-chloro-3-pyridinyl)methyl]-2-thiazolidinylidene]cyanamide; Thiacloprid [ISO:BSI]; Cyanamide, (3-((6-chloro-3-pyridinyl)methyl)-2-thiazolidinylidene)-; HSDB 7268; (Z)-[3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene]cyanamide; DSSTox_CID_14961; DSSTox_RID_79228; DSSTox_GSID_34961; SCHEMBL26490; SCHEMBL26491; SCHEMBL237347; DTXSID7034961; CTK8G5807; HY-B1953; Tox21_300697; BDBM50251868; MFCD09028056; ZINC13828082; AKOS015897524; ZINC100057010; ZINC255976955; DB08620; CID 6011129; NCGC00164441-01; NCGC00164441-02; NCGC00164441-03; NCGC00164441-04; NCGC00254605-01; AS-35094; AT-19629; Thiacloprid 10 microg/mL in Acetonitrile; DB-017476; CS-0014056; FT-0657423; C18512; Thiacloprid, PESTANAL(R), analytical standard; 988T499; A802461; Q416283; J-002682; Q63408702; Thiacloprid, certified reference material, TraceCERT(R); N-(3-((6-Chloropyridin-3-yl)methyl)thiazolidin-2-ylidene)cyanamide; (E)-[3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene]cyanamide; (E)-N-(3-((6-chloropyridin-3-yl)methyl)thiazolidin-2-ylidene)cyanamide; (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; (Z)-N-(3-((6-Chloropyridin-3-yl)methyl)thiazolidin-2-ylidene)cyanamide; [3-[(6-chloranylpyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene]cyanamide; N-(3-(6-chloro-pyridin-3-ylmethyl)-thiazolidin-2-ylidene)-cyanamide